It’s a sterile and stable Hemostatic agent.
Cessation of blood loss from a damaged vessel followed by repair.
The hemostatic effect is enabled by ABS products interacting with blood proteins (particularly fibrinogen) to form a protein network that promotes erythrocyte aggregation.
It takes <1 second for external wounds and 3-5 seconds for surgical wounds to have hemostasis upon applying ABS to the bleeding area.
It causes a temporary skin texture/color change due to high iron content.
No, ABS products do not require special storage conditions.
There is no known side effect from ABS product use.
Individuals of all ages can use ABS products, including children and the elderly.
No, ABS products do not have adverse drug interactions. The products do not interfere with the patient’s use of medication, such as warfarin, heparin & aspirin
All patients, including diabetic, hemophilic, and hypertensive patients, can use ABS. Pregnant mothers and patients with coagulation disorders can equally use the products.
Ankaferd was founded in 2005 in Istanbul, Turkey.
Yes. ABS products have been licensed for use by the Kenyan Pharmacy & Poisons Board, the European Union, and certified by the Conformité Européenne. This mark signifies that the product has met safety, health, and environmental requirements, and is thus safe for consumer use.